2012 american college of cardiology, 61st annual scientific session & expo.

نویسنده

  • Walter Alexander
چکیده

Progression to MI occurred in 49% of subjects in the GIK group and in 52% of those in the placebo group (P = 0.28). Thirty-day mortality rates were 4% with GIK and 6% for placebo (P = 0.27). The endpoint of cardiac arrest or hospital mortality significantly favored GIK (4% and 6%, respectively, P = 0.01). Similar patterns were found for patients presenting with STEMI, again with a significant advantage for GIK in the endpoint of cardiac arrest or hospital mortality (6% GIK, 14% placebo; P = 0.01). Further significant benefits for GIK, compared with placebo, were reported for 30-day infarct size and FFA levels. Glucose levels above 300 mg/dL, as expected, occurred significantly more often in GIK-treated patients with and without diabetes. Rates of adverse effects with GIK were low, and the drug’s cost, Dr. Selker underscored, is low. He concluded that the risk of cardiac arrest or death was reduced by half in the IMMEDIATE trial among patients with ACS and STEMI when paramedics administered intravenous GIK as soon as possible.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

American College of Cardiology.

We report on selected research presented at the ACC 66th Annual Scientific Session and Expo, including sessions on proprotein convertase subtilisin/kexin type 9 inhibitors, anti-Xa anticoagulants, and a direct thrombin inhibitor.

متن کامل

Selected highlights from the 50th Annual Scientific Session of the American College of Cardiology, Orlando, USA, 18-21 March 2001

The recent scientific session of the American College of Cardiology (ACC), held in Orlando, provided a forum for ongoing cardiovascular clinical trials from around the world. The high point was clearly the first ever release of results from the CURE study. The Late-Breaking Clinical Trials sessions also featured results and interim data from other trials such as MIRACLE, CAPRICORN, SVG WRIST, R...

متن کامل

Clinical trials update: highlights of the scientific sessions of The American College of Cardiology 2002: LIFE, DANAMI 2, MADIT-2, MIRACLE-ICD, OVERTURE, OCTAVE, ENABLE 1 & 2, CHRISTMAS, AFFIRM, RACE, WIZARD, AZACS, REMATCH, BNP trial and HARDBALL.

This article continues a series of reports updating recent research developments of particular interest to personnel involved in the treatment and management of patients with heart failure. This is a summary of selected presentations made at the American College of Cardiology 51st Annual Scientific Session held in Atlanta on 17-20 March 2002. Reports of the following clinical studies are includ...

متن کامل

Bedside cardiology skills training for the osteopathic internist using simulation technology.

Medical practice changes that limit patient availability, instructor time, and advances in technology have led to a greater use of simulators and multimedia computers in medical education. These systems address the problem of inadequate bedside skills training and poor proficiency among all health care providers. While studies have shown their effectiveness among medical students, residents, an...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • P & T : a peer-reviewed journal for formulary management

دوره 37 5  شماره 

صفحات  -

تاریخ انتشار 2012